Derek T. Chalmers, President & CEO at Cara Therapeutics, Inc. (CARA), sold 5,071 shares at $16.00 ($81K) on 2020-05-21, disclosed to the SEC on 2020-05-22.
Open-market sale of $81k CARA by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.00 | 1,200 | $19K | 23.7% |
| 2 | $16.00 | 3,500 | $56K | 69.0% |
| 3 | $16.00 | 371 | $6K | 7.3% |
| Total | $16.00 avg | 5,071 | $81K | 100% |
| Filing → |
| CARA | SELL | 2021-03-08 | $112K | — | Filing → |
| CARA | SELL | 2021-02-25 | $453K | — | Filing → |
| CARA | SELL | 2020-12-30 | $186K | — | Filing → |